144 related articles for article (PubMed ID: 36385359)
1. Clinical and Genetic Characterization of Patients with Artemis Deficiency in Japan.
Inoue K; Miyamoto S; Tomomasa D; Adachi E; Azumi S; Horikoshi Y; Ishihara T; Osone S; Kawahara Y; Kudo K; Kato Z; Ohnishi H; Kashimada K; Imai K; Ohara O; van Zelm MC; Cowan MJ; Morio T; Kanegane H
J Clin Immunol; 2023 Apr; 43(3):585-594. PubMed ID: 36385359
[TBL] [Abstract][Full Text] [Related]
2. Lentivirus Mediated Correction of Artemis-Deficient Severe Combined Immunodeficiency.
Punwani D; Kawahara M; Yu J; Sanford U; Roy S; Patel K; Carbonaro DA; Karlen AD; Khan S; Cornetta K; Rothe M; Schambach A; Kohn DB; Malech HL; McIvor RS; Puck JM; Cowan MJ
Hum Gene Ther; 2017 Jan; 28(1):112-124. PubMed ID: 27611239
[TBL] [Abstract][Full Text] [Related]
3. Functional analysis of naturally occurring DCLRE1C mutations and correlation with the clinical phenotype of ARTEMIS deficiency.
Felgentreff K; Lee YN; Frugoni F; Du L; van der Burg M; Giliani S; Tezcan I; Reisli I; Mejstrikova E; de Villartay JP; Sleckman BP; Manis J; Notarangelo LD
J Allergy Clin Immunol; 2015 Jul; 136(1):140-150.e7. PubMed ID: 25917813
[TBL] [Abstract][Full Text] [Related]
4. SCID patients with ARTEMIS vs RAG deficiencies following HCT: increased risk of late toxicity in ARTEMIS-deficient SCID.
Schuetz C; Neven B; Dvorak CC; Leroy S; Ege MJ; Pannicke U; Schwarz K; Schulz AS; Hoenig M; Sparber-Sauer M; Gatz SA; Denzer C; Blanche S; Moshous D; Picard C; Horn BN; de Villartay JP; Cavazzana M; Debatin KM; Friedrich W; Fischer A; Cowan MJ
Blood; 2014 Jan; 123(2):281-9. PubMed ID: 24144642
[TBL] [Abstract][Full Text] [Related]
5. A Novel Non-Coding Variant in DCLRE1C Results in Deregulated Splicing and Induces SCID Through the Generation of a Truncated ARTEMIS Protein That Fails to Support V(D)J Recombination and DNA Damage Repair.
Strubbe S; De Bruyne M; Pannicke U; Beyls E; Vandekerckhove B; Leclercq G; De Baere E; Bordon V; Vral A; Schwarz K; Haerynck F; Taghon T
Front Immunol; 2021; 12():674226. PubMed ID: 34220820
[TBL] [Abstract][Full Text] [Related]
6. Radiosensitive SCID patients with Artemis gene mutations show a complete B-cell differentiation arrest at the pre-B-cell receptor checkpoint in bone marrow.
Noordzij JG; Verkaik NS; van der Burg M; van Veelen LR; de Bruin-Versteeg S; Wiegant W; Vossen JM; Weemaes CM; de Groot R; Zdzienicka MZ; van Gent DC; van Dongen JJ
Blood; 2003 Feb; 101(4):1446-52. PubMed ID: 12406895
[TBL] [Abstract][Full Text] [Related]
7. The many faces of Artemis-deficient combined immunodeficiency - Two patients with DCLRE1C mutations and a systematic literature review of genotype-phenotype correlation.
Lee PP; Woodbine L; Gilmour KC; Bibi S; Cale CM; Amrolia PJ; Veys PA; Davies EG; Jeggo PA; Jones A
Clin Immunol; 2013 Dec; 149(3):464-74. PubMed ID: 24230999
[TBL] [Abstract][Full Text] [Related]
8. Artemis deficiency: A large cohort including a novel variant with increased radiosensitivity.
Meric Z; Gemici Karaaslan B; Yalcin Gungoren E; Bektas Hortoglu M; Cavas T; Aydemir S; Bilgic Eltan S; Firtina S; Kendir Demirkol Y; Eser M; Cekic S; Kilic S; Karasu G; Yesilipek MA; Eke Gungor H; Karakoc-Aydiner E; Ozen A; Baris S; Yucel E; Cokugras H; Kiykim A
Pediatr Allergy Immunol; 2024 Jun; 35(6):e14171. PubMed ID: 38860449
[TBL] [Abstract][Full Text] [Related]
9. Novel Artemis gene mutations of radiosensitive severe combined immunodeficiency in Japanese families.
Kobayashi N; Agematsu K; Sugita K; Sako M; Nonoyama S; Yachie A; Kumaki S; Tsuchiya S; Ochs HD; Sugita K; Fukushima Y; Komiyama A
Hum Genet; 2003 Apr; 112(4):348-52. PubMed ID: 12592555
[TBL] [Abstract][Full Text] [Related]
10. Severe combined immunodeficiency (SCID) presenting in childhood, with agammaglobulinemia, associated with novel compound heterozygous mutations in DCLRE1C.
Sundin M; Marits P; Ramme K; Kolios AGA; Nilsson J
Clin Immunol; 2019 Mar; 200():16-18. PubMed ID: 30630113
[TBL] [Abstract][Full Text] [Related]
11. DCLRE1C (ARTEMIS) mutations causing phenotypes ranging from atypical severe combined immunodeficiency to mere antibody deficiency.
Volk T; Pannicke U; Reisli I; Bulashevska A; Ritter J; Björkman A; Schäffer AA; Fliegauf M; Sayar EH; Salzer U; Fisch P; Pfeifer D; Di Virgilio M; Cao H; Yang F; Zimmermann K; Keles S; Caliskaner Z; Güner SÜ; Schindler D; Hammarström L; Rizzi M; Hummel M; Pan-Hammarström Q; Schwarz K; Grimbacher B
Hum Mol Genet; 2015 Dec; 24(25):7361-72. PubMed ID: 26476407
[TBL] [Abstract][Full Text] [Related]
12. Lentiviral Gene Therapy for Artemis-Deficient SCID.
Cowan MJ; Yu J; Facchino J; Fraser-Browne C; Sanford U; Kawahara M; Dara J; Long-Boyle J; Oh J; Chan W; Chag S; Broderick L; Chellapandian D; Decaluwe H; Golski C; Hu D; Kuo CY; Miller HK; Petrovic A; Currier R; Hilton JF; Punwani D; Dvorak CC; Malech HL; McIvor RS; Puck JM
N Engl J Med; 2022 Dec; 387(25):2344-2355. PubMed ID: 36546626
[TBL] [Abstract][Full Text] [Related]
13. Novel spontaneous deletion of artemis exons 10 and 11 in mice leads to T- and B-cell deficiency.
Barthels C; Puchałka J; Racek T; Klein C; Brocker T
PLoS One; 2013; 8(9):e74838. PubMed ID: 24069355
[TBL] [Abstract][Full Text] [Related]
14. Compound heterozygous DCLRE1C mutations lead to clinically typical Severe Combined Immunodeficiency presenting with Graft Versus Host Disease.
Mou W; Gao L; He J; Yin J; Xu B; Gui J
Immunogenetics; 2021 Dec; 73(6):425-434. PubMed ID: 34406419
[TBL] [Abstract][Full Text] [Related]
15. The most frequent DCLRE1C (ARTEMIS) mutations are based on homologous recombination events.
Pannicke U; Hönig M; Schulze I; Rohr J; Heinz GA; Braun S; Janz I; Rump EM; Seidel MG; Matthes-Martin S; Soerensen J; Greil J; Stachel DK; Belohradsky BH; Albert MH; Schulz A; Ehl S; Friedrich W; Schwarz K
Hum Mutat; 2010 Feb; 31(2):197-207. PubMed ID: 19953608
[TBL] [Abstract][Full Text] [Related]
16. Defective DNA repair and increased genomic instability in Artemis-deficient murine cells.
Rooney S; Alt FW; Lombard D; Whitlow S; Eckersdorff M; Fleming J; Fugmann S; Ferguson DO; Schatz DG; Sekiguchi J
J Exp Med; 2003 Mar; 197(5):553-65. PubMed ID: 12615897
[TBL] [Abstract][Full Text] [Related]
17. Long-Term Health Outcome and Quality of Life Post-HSCT for IL7Rα-, Artemis-, RAG1- and RAG2-Deficient Severe Combined Immunodeficiency: a Single Center Report.
Abd Hamid IJ; Slatter MA; McKendrick F; Pearce MS; Gennery AR
J Clin Immunol; 2018 Aug; 38(6):727-732. PubMed ID: 30105620
[TBL] [Abstract][Full Text] [Related]
18. ADA Deficiency: Evaluation of the Clinical and Laboratory Features and the Outcome.
Cagdas D; Gur Cetinkaya P; Karaatmaca B; Esenboga S; Tan C; Yılmaz T; Gümüş E; Barış S; Kuşkonmaz B; Ozgur TT; Bali P; Santisteban I; Orhan D; Yüce A; Cetinkaya D; Boztug K; Hershfield M; Sanal O; Tezcan İ
J Clin Immunol; 2018 May; 38(4):484-493. PubMed ID: 29744787
[TBL] [Abstract][Full Text] [Related]
19. Targeted disruption of the Artemis murine counterpart results in SCID and defective V(D)J recombination that is partially corrected with bone marrow transplantation.
Li L; Salido E; Zhou Y; Bhattacharyya S; Yannone SM; Dunn E; Meneses J; Feeney AJ; Cowan MJ
J Immunol; 2005 Feb; 174(4):2420-8. PubMed ID: 15699179
[TBL] [Abstract][Full Text] [Related]
20. DNA recombination defects in Kuwait: Clinical, immunologic and genetic profile.
Al-Herz W; Massaad MJ; Chou J; Notarangelo LD; Geha RS
Clin Immunol; 2018 Feb; 187():68-75. PubMed ID: 29051008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
